Does INFLIXIMAB Cause Product use issue? 12,752 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 12,752 reports of Product use issue have been filed in association with INFLIXIMAB (Renflexis). This represents 9.1% of all adverse event reports for INFLIXIMAB.
12,752
Reports of Product use issue with INFLIXIMAB
9.1%
of all INFLIXIMAB reports
1,066
Deaths
3,577
Hospitalizations
How Dangerous Is Product use issue From INFLIXIMAB?
Of the 12,752 reports, 1,066 (8.4%) resulted in death, 3,577 (28.1%) required hospitalization, and 1,392 (10.9%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 12,752 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB Cause?
Off label use (34,801)
Drug ineffective (33,738)
Condition aggravated (16,616)
Rheumatoid arthritis (16,251)
Pain (15,061)
Fatigue (13,473)
Arthralgia (13,441)
Infusion related reaction (12,946)
Drug intolerance (11,173)
Intentional product use issue (11,028)
What Other Drugs Cause Product use issue?
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
CETIRIZINE (5,771)
Which INFLIXIMAB Alternatives Have Lower Product use issue Risk?
INFLIXIMAB vs INFLIXIMAB-ABDA
INFLIXIMAB vs INFLIXIMAB-AXXQ
INFLIXIMAB vs INFLIXIMAB-DYYB
INFLIXIMAB vs INFLIXIMAB-QBTX
INFLIXIMAB vs INFLIXIMAB, RECOMBINANT